Hcv vaccine compositions comprising e1 and ns3 peptides

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/29 (2006.01) C07K 14/18 (2006.01)

Patent

CA 2504711

The invention relates to immunogenic and vaccine compositions useful in prophylactic and therapeutic treatment of HCV infection. More specifically, said compositions comprise a HCV envelope peptide E1 and a HCV non-structural peptide NS3.

L'invention concerne des compositions immunogènes et de vaccins, utiles dans le traitement prophylactique et thérapeutique des infections par virus HC. Elle concerne plus particulièrement des compositions comprenant un peptide d'enveloppe du virus HC et un peptide non structurel du virus HC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hcv vaccine compositions comprising e1 and ns3 peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv vaccine compositions comprising e1 and ns3 peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv vaccine compositions comprising e1 and ns3 peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1444887

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.